Overview

Deep learning extends classical neural networks by stacking many hidden layers, enabling the automatic learning of hierarchical representations from raw or minimally processed data. In bioinformatics, this approach has proven transformative for data types with inherent spatial or sequential structure — DNA sequences, protein structures, and biomedical images. Deep models discover relevant features directly from the data, bypassing the need for hand-crafted feature engineering that traditionally dominated the field.

Methods

Convolutional neural networks (CNNs) apply sliding filters to detect local patterns such as transcription factor binding motifs in sequences or structural features in protein contact maps. Recurrent neural networks (RNNs) and their gated variants (LSTMs, GRUs) model sequential dependencies and are used for predicting RNA secondary structure and protein localization. Transformer architectures with self-attention mechanisms, exemplified by AlphaFold and DNABERT, capture long-range interactions and have set new standards in protein structure prediction and regulatory genomics. Graph neural networks operate on molecular graphs for drug property prediction. Training these models requires large labeled datasets, GPU acceleration, and techniques such as dropout and batch normalization to prevent overfitting.

Applications

Deep learning powers AlphaFold’s accurate protein structure predictions, interprets DNA sequencing reads for variant detection, and deconvolutes complex expression patterns from DNA microarrays and gene expression assays. It also enables single-cell analysis, drug discovery, and medical image diagnosis, establishing itself as a cornerstone of modern computational biology.